Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials

Molecular Aspects of Medicine

Volumn 18, Issue SUPPL., 1997, Pages 159-168

  Soja, A M ^a,c   Mortensen, S A ^b  

^a Sct Elisabeth Hospital of Copenhagen   (Denmark)

^b Rigshospitalet   (Denmark)

^c NONE   (Denmark)

Author keywords

Coenzyme Q10; CoQ10; Heart failure; Meta analysis

Indexed keywords

UBIDECARENONE;

CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEART EJECTION FRACTION; HEART FAILURE; HEART INDEX; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; SYSTOLIC TIME INTERVAL; WORK CAPACITY;

EID: 0030777310     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(97)00042-3     Document Type: Conference Paper

References (30)

1. Draborg, E. U. (1994) Meta-analysis - a method of statistic aggregation. Centre for Health and Social Policy, University of Odense.
2. 10 in human heart disease. International Journal of Vitamin and Nutrition Research, 40, 380-390.
3. Folkers, K., Watanabe, T. and Kaji, M. J. (1977). Critique of coenzyme Q in biochemical and biomedical research and in ten years of clinical research on cardiovascular disease. Journal of Molecular Medicine, 2, 431-460.
4. 10. Proceedings of the National Academy of Sciences of the USA, 82, 901-904.
5. Hedges, L. V. J. (1981). Distribution theory for Glass's estimator of effect size and related estimators. Educational Statistics, 6, 2 107-128.
6. 10 in heart failure. In Biomedical and Clinical Aspects of Coenzyme Q, eds K. Folkers and Y. Yamamura, Vol. 5, pp. 315-323. Elsevier, Amsterdam.
7. 10 treated chronic heart failure patients compared to conventionally treated patients. In Biomedical and Clinical Aspects of Coenzyme Q, eds K. Folkers, G. P. Littarru and T. Yamagami, Vol. 6, pp. 291-298. Elsevier, Amsterdam.
8. Karlsson, J., Diamant, B., Theorell, H. and Folkers, K. (1993). Ubiquinone and α-tocopherol in plasma; means of translocation or depot. The Clinical Investigator, 71, 84-91.
9. 10 in patients with cardiac failure. In Biomedical and Clinical Aspects of CoQ, eds K. Folkers and Y. Yamamura, Vol. 4, pp. 243-252. Elsevier, Amsterdam.
10. 10. Proceedings of the National Academy of Sciences of the USA, 82, 4240-4244.
11. 10 of patients with chronic myocardiel disease. Drugs Under Experimental and Clinical Research, IX, 8 577-579.
12. Lenaz, G. (1985) A biochemical rationale for the therapeutic effects of CoQ. In Coenzyme Q, ed. G. Lenaz, Chap. XX, pp. 435-440. John Wiley, Chichester.
13. 10 content in different parts of the normal human heart. Clinical Physiology, 8, 391-398.
14. 10 in human heart disease. Part I and II. International Journal of Vitamin and Nutrion Research, 42, 294-434.
15. 10 therapy in patients with congestive heart failure: a long term multicenter randomized study. The Clinical Investigator, 71, 134-136.
16. 10 treatment. Molecular Aspects of Medicine, 15, 155-163.
17. Mortensen, S. A. (1989) Endomyocardial biopsy. Technical aspects and indications. Thesis, pp. 3-36.
18. 10. The Clinical Investigator, 71, 116-123.
19. 10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronical heart failure. International Journal of Tissue Reactions, XII, 3 155-162.
20. 10 und vitamin E bei hertzkranken patienten. De orthomoleculaire Koerier, 5, 24 4-11.
21. 10) in the long-term treatment of idiopatic dilated cardiomyopathy. European Heart Journal, 13, 1528-1533.
22. 10 on left ventricular function in patients with dilative cardiomyopathy. Current Therapy and Research, 49, 5 878-886.
23. Rengo, F., Abete, P., Landino, P., Leosco, D., Covelluzzi, F. and Vitale, D. et al. (1993). Role of metabolic therapy in cardiovascular disease. The Clinical Investigator, 71, 124-128.
24. 10 in ischemic cardiopathy. In Biomedical and Clinical Aspects of Coenzyme Q, eds K. Folkers, G. P. Littarru and T. Yamagami, Vol. 6, pp. 321-326. Elsevier, Amsterdam.
25. Sacks, H. S., Berrier, J., Reitman, D., Ancona-Beck, V. A. and Chalmers, T. C. (1987). Meta-analyses of randomized controlled trials. New England Journal of Medicine, 316, 450-455.
26. 10 on patients with cardiac disease. In Biomedical and Clinical Aspects of Coenzyme Q, eds K. Folkers and Y. Yamamura, Vol. 5, pp. 325-333. Elsevier, Amsterdam.
27. 10 in patients awaiting cardiac transplantation. Transplant Proceedings, 25, 2365-2367.
28. 10 in patients with moderate heart failure and chronic stable effort angina. In Biomedical and Clinical Aspects of Coenzyme Q, eds K. Folkers, G. P. Littarru and T. Yamagami, Vol. 6, pp. 327-338. Elsevier, Amsterdam.
29. 10 as an adjunctive in treatment of congestive heart failure. Journal of Cardiac Failure, 1, 2 101-107.
30. 10 on physical performance and recovery in myocardial failure. In Biomedical and Clinical Aspects of Coenzyme Q, eds K. Folkers and Y. Yamamura, Vol. 5, pp. 371-377. Elsevier, Amsterdam.